BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mccarthy AR, Hollick JJ, Westwood NJ. The discovery of nongenotoxic activators of p53: Building on a cell-based high-throughput screen. Seminars in Cancer Biology 2010;20:40-5. [DOI: 10.1016/j.semcancer.2010.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ter Braak B, Niemeijer M, Wolters L, Le Dévédec S, Bouwman P, van de Water B. Towards an advanced testing strategy for genotoxicity using image-based 2D and 3D HepG2 DNA damage response fluorescent protein reporters. Mutagenesis 2021:geab031. [PMID: 34448005 DOI: 10.1093/mutage/geab031] [Reference Citation Analysis]
2 Meng H, Mcclendon CL, Dai Z, Li K, Zhang X, He S, Shang E, Liu Y, Lai L. Discovery of Novel 15-Lipoxygenase Activators To Shift the Human Arachidonic Acid Metabolic Network toward Inflammation Resolution. J Med Chem 2016;59:4202-9. [DOI: 10.1021/acs.jmedchem.5b01011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
3 Koca İ, Özgür A, Coşkun KA, Tutar Y. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety. Bioorg Med Chem 2013;21:3859-65. [PMID: 23664495 DOI: 10.1016/j.bmc.2013.04.021] [Cited by in Crossref: 114] [Cited by in F6Publishing: 88] [Article Influence: 12.7] [Reference Citation Analysis]
4 MacCallum SF, Groves MJ, James J, Murray K, Appleyard V, Prescott AR, Drbal AA, Nicolaou A, Cunningham J, Haydock S, Ganley IG, Westwood NJ, Coates PJ, Lain S, Tauro S. Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6. Sci Rep 2013;3:1275. [PMID: 23429453 DOI: 10.1038/srep01275] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
5 Li C, Deng X, Zhang W, Xie X, Conrad M, Liu Y, Angeli JPF, Lai L. Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4. J Med Chem 2019;62:266-75. [PMID: 29688708 DOI: 10.1021/acs.jmedchem.8b00315] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
6 Harakandi C, Nininahazwe L, Xu H, Liu B, He C, Zheng YC, Zhang H. Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy. Bioorg Chem 2021;116:105273. [PMID: 34474304 DOI: 10.1016/j.bioorg.2021.105273] [Reference Citation Analysis]
7 McCarthy AR, Pirrie L, Hollick JJ, Ronseaux S, Campbell J, Higgins M, Staples OD, Tran F, Slawin AM, Lain S, Westwood NJ. Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins. Bioorg Med Chem 2012;20:1779-93. [PMID: 22304848 DOI: 10.1016/j.bmc.2012.01.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]